SCNI

Scinai Immunotherapeutics
SCNI

Overview Fund Trends Analyst Outlook Journalist POV

6 hedge funds and large institutions have $367K invested in Scinai Immunotherapeutics in 2017 Q1 according to their latest regulatory filings, with 4 funds opening new positions, increasing their positions, 0 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

more ownership

Funds ownership: →

Holders
6
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$177K
2
+$83K
3
+$5K
4
TRCT
Tower Research Capital (TRC)
New York
+$1K

Top Sellers

1
-$44K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$177K
2
$99K
3
$83K
4
$5K
5
$2K
6
$1K
7
–